Cardiovascular device development: An FDA perspective

American Journal of Therapeutics

Volumn 12, Issue 2, 2005, Pages 176-178

  Zuckerman, Bram D ^a,b   Muni, Neal I ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL HEART PACEMAKER; CONFERENCE PAPER; CORONARY STENT; DECISION MAKING; DEVICE; ELECTROCARDIOGRAPHY; EVALUATION; FOOD AND DRUG ADMINISTRATION; HUMAN; MARKETING; MEDICAL INSTRUMENTATION; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SAFETY;

CARDIOLOGY; DEVICE APPROVAL; HUMANS; PROSTHESES AND IMPLANTS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 17144364347     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000155115.66222.3c     Document Type: Conference Paper

References (1)

1. Moseley JB, O'Malley K, Petersen NJ, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002;347:81-88.